| Literature DB >> 8875750 |
C Daumerie1, S Vynckier, J Caussin, M Jadoul, J P Squifflet, N de Patoul, A Wambersie.
Abstract
To deliver optimal radioiodine activity in hemodialyzed patients with thyroid carcinoma, the behavior of radioiodine was followed during six treatments. During hemodialysis, blood activity decreases with a half-life of 3.4 +/- 0.5, (1SD) h. The whole body dose was calculated from the total activity determined during 10 days after 131I administration. A reasonable strategy may consist in delivering 25% of the currently prescribed activity (925 MBq-25 mCi) and to perform the first dialysis session after 24 h to reduce total body irradiation.Entities:
Mesh：
Substances：
Year: 1996 PMID： 8875750 DOI： 10.1089/thy.1996.6.301
Source DB: PubMed Journal: Thyroid ISSN： 1050-7256 Impact factor: 6.568